Global Clinical Data Management Systems (CDMS) Market
The Global Clinical Data Management Systems (CDMS) Market was valued at USD 1532.18 million in 2021 which is expected to reach 4,270.94 million by 2027 at a CAGR 15.4% from 2022-2027.
A Clinical Data Management Systems or (CDMS) is an appliance used in clinical research to maintain the data of clinical trial. The clinical trial data assembled at the investigator site in the case report form are put down in the CDMS. To minimize the chances of miscalculation because of human entry, the systems hire various means to verify the data.
Market Drivers
Increasing number of clinical trials is the key factor to drive the clinical data management market.
Benefit of web- based data collection device such as shorten time & relaxation in data entry, low price, flexibility in format and the potential to capture additional response set information boost the clinical data management market. Additionally high level of productivity and efficiency provided by clinical data management are expected to redefine the traditional data management process by the companies thereby multiplying the clinical data management market growth. Likewise rise in Research & Development expenditure of clinical research & Life Sciences industries conjugate with growing number of clinical trials is a factor contributing to the development of clinical data management market.
Market Restraints
Data collection leads to worry surrounding patient privacy chiefly in electronic data capture segment that may act as restraint in the market growth. The increase in exchange of database amongst CROs, research institute, software companies & different stakeholders, raise the risk of data violation. Simple access and effortless sharing generally required opening data so that data can be used and share which will leads to restrain the clinical data management market growth.
This can further reveal components of a company to digital security warnings conceivably arise into incidents such as data violation affecting the confidentiality, integrity or availability of data and information system on which social and economic activities depends. Such increasing concern of data ejaculation may restrict the acquisition of clinical data management system, so that hampering the market expansion.
Market Segmentation
The Global Clinical Data Management Systems (CDMS) Market is segmented into Delivery Mode, End-user, Application. By Delivery Mode such as Licensed Enterprise Solutions, Cloud-based Solutions, Web-hosted Solutions. By End User such as Contract Research Organizations, Medical Device Companies, Pharma/Biotech Companies. By Application such as Hospitals, CROs, Pharma & Biotech Organisations, Others.
Regional Analysis
The Global Clinical Data Management Systems (CDMS) Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America considered for 46.5% of the global clinical data management system market in 2021. During the forecast period the Global Clinical Data Management Systems (CDMS) Market is expected to grow owing to wide-ranging drug development activities in North America. The increasing growth of Global Clinical Data Management Systems (CDMS) Market in Asia Pacific is credited to a number of components including rise in outsourcing of clinical trial, availability of diverse patient population & less regulatory guidelines by government.
Key Players
Various Key Players are listed in this report such as Medidata, Oracle, IBM, PAREXEL Informatics, BioClinica, Medrio, Forte Research Systems, Taimei Technology, Ofni Systems, Fortress Medical Systems.
Market Taxonomy
By Delivery Mode
By End User
By Application
By Region
Global Clinical Data Management Systems (CDMS) Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Clinical Data Management Systems (CDMS) Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Clinical Data Management Systems (CDMS) Market, By Delivery Mode
5.1 Y-o-Y Growth Comparison, By Delivery Mode
5.2 Global Clinical Data Management Systems (CDMS) Market Share Analysis, By Delivery Mode
5.3 Global Clinical Data Management Systems (CDMS) Market Size and Forecast, By Delivery Mode
5.3.1 Licensed Enterprise Solutions
5.3.2 Cloud-based Solutions
5.3.3 Web-hosted Solutions
6 Global Clinical Data Management Systems (CDMS) Market, By Application
6.1 Y-o-Y Growth Comparison, By End User
6.2 Global Clinical Data Management Systems (CDMS) Market Share Analysis, By Application
6.3 Global Clinical Data Management Systems (CDMS) Market Size and Forecast, By Application
6.3.1 Hospitals
6.3.2 CROs
6.3.3 Pharma & Biotech Organisations
6.3.4 Others.
7 Global Clinical Data Management Systems (CDMS) Market, By End-user industry
7.1 Y-o-Y Growth Comparison, By End-user industry
7.2 Global Clinical Data Management Systems (CDMS) Market Share Analysis, By End-user industry
7.3 Global Clinical Data Management Systems (CDMS) Market Size and Forecast, By End-user industry
7.3.1 Contract Research Organizations
7.3.2 Medical Device Companies
7.3.3 Pharma/Biotech Companies
8 Global Clinical Data Management Systems (CDMS) Market, By Region
8.1 Global Clinical Data Management Systems (CDMS) Market Share Analysis, By Region
8.2 Global Clinical Data Management Systems (CDMS) Market Share Analysis, By Region
8.3 Global Clinical Data Management Systems (CDMS) Market Size and Forecast, By Region
9 North America Clinical Data Management System (CDMS) Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Clinical Data Management System (CDMS) Share Analysis, By Delivery Mode
9.3 North America Clinical Data Management System (CDMS) Size and Forecast, By End User
9.4 North America Clinical Data Management System (CDMS) Size and Forecast, By Application
9.5 North America Clinical Data Management System (CDMS) Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Clinical Data Management System (CDMS) Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Clinical Data Management System (CDMS) Share Analysis, By Delivery Mode
10.3 Europe Clinical Data Management System (CDMS) Size and Forecast, By End User
10.4 Europe Clinical Data Management System (CDMS) Size and Forecast, Application
10.5 Europe Clinical Data Management System (CDMS) Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific Clinical Data Management System (CDMS) Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Clinical Data Management System (CDMS) Share Analysis, By Delivery Mode
11.3 Asia Pacific Clinical Data Management System (CDMS) Size and Forecast, By End User
11.4 Asia Pacific Clinical Data Management System (CDMS) Size and Forecast, Application
11.5 Asia Pacific Clinical Data Management System (CDMS) Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Clinical Data Management System (CDMS) Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Clinical Data Management System (CDMS) Share Analysis, By Delivery Mode
12.3 Latin America Clinical Data Management System (CDMS) Size and Forecast, By End User
12.4 Latin America Clinical Data Management System (CDMS) Size and Forecast, By Application
12.5 Latin America Clinical Data Management System (CDMS) Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East Clinical Data Management System (CDMS) Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Clinical Data Management System (CDMS) Share Analysis, By Delivery Mode
13.3 Middle East Clinical Data Management System (CDMS) Size and Forecast, By End User
13.4 Middle East Clinical Data Management System (CDMS) Size and Forecast, By Application
13.5 Middle East Clinical Data Management System (CDMS) Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Medidata
15.1.1 Overview
15.1.2 Types
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Oracle
15.2.1 Overview
15.2.2 Types
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 IBM
15.3.1 Overview
15.3.2 Types
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 PAREXEL Informatics
15.4.1 Overview
15.4.2 Types
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 BioClinica
15.5.1 Overview
15.5.2 Types
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Medrio
15.6.1 Overview
15.6.2 Types
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Forte Research Systems
15.7.1 Overview
15.7.2 Types
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Taimei Technology
15.8.1 Overview
15.8.2 Types
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Ofni Systems
15.9.1 Overview
15.9.2 Types
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Fortress Medical Systems.
15.10.1 Overview
15.10.2 Types
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
